Peginterferon alfa-2a Interactions
There are 230 drugs known to interact with peginterferon alfa-2a, along with 10 disease interactions. Of the total drug interactions, 40 are major, 185 are moderate, and 5 are minor.
- View all 230 medications that may interact with peginterferon alfa-2a
- View peginterferon alfa-2a disease interactions (10)
Most frequently checked interactions
View interaction reports for peginterferon alfa-2a and the medicines listed below.
- Acetylsalicylic Acid (aspirin)
- Acetylsalicylic Acid (aspirin)
- Augmentin (amoxicillin / clavulanate)
- Augmentin (amoxicillin / clavulanate)
- Incivek (telaprevir)
- Incivek (telaprevir)
- Klonopin (clonazepam)
- Klonopin (clonazepam)
- Lamictal (lamotrigine)
- Lamictal (lamotrigine)
- Lexapro (escitalopram)
- Lexapro (escitalopram)
- Lithium Carbonate ER (lithium)
- Lithium Carbonate ER (lithium)
- Nexium (esomeprazole)
- Nexium (esomeprazole)
- Paracetamol (acetaminophen)
- Paracetamol (acetaminophen)
- Quercetin (bioflavonoids)
- Quercetin (bioflavonoids)
- RibaPak (ribavirin)
- RibaPak (ribavirin)
- Topamax (topiramate)
- Topamax (topiramate)
- Vitamin B1 (thiamine)
- Vitamin B1 (thiamine)
- Vitamin D3 (cholecalciferol)
- Vitamin D3 (cholecalciferol)
- Xarelto (rivaroxaban)
- Xarelto (rivaroxaban)
Peginterferon alfa-2a disease interactions
There are 10 disease interactions with peginterferon alfa-2a which include:
- renal dysfunction
- autoimmune diseases
- cardiac disease
- autoimmune hepatitis
- depression
- severe hepatic disease
- bone marrow suppression
- endocrine disorders
- ophthalmological disorders
- pulmonary disorders
More about peginterferon alfa-2a
- peginterferon alfa-2a consumer information
- Compare alternatives
- Reviews (19)
- Side effects
- Dosage information
- During pregnancy
- Drug class: antiviral interferons
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
See also:
Epclusa
Epclusa treats chronic hepatitis C in adults and children 3+. This once-daily antiviral combines ...
Mavyret
Mavyret (glecaprevir/pibrentasvir) is an oral combination medicine containing fixed doses of two ...
Botox
Botox is used for cosmetic purposes and to treat overactive bladder symptoms, urinary incontinence ...
Vemlidy
Vemlidy (tenofovir alafenamide) is an oral, once-daily, antiviral tablet that may be used to treat ...
Harvoni
Harvoni is used to treat hepatitis C virus (HCV) infections in adults and children aged 3 years and ...
Viread
Viread (tenofovir) is used to treat HIV, which causes the acquired immunodeficiency syndrome ...
Lamivudine
Lamivudine systemic is used for hepatitis b, HIV Infection, nonoccupational exposure, occupational ...
Sofosbuvir/velpatasvir
Sofosbuvir-velpatasvir (brand name Epclusa) is used to treat chronic hepatitis C (HCV) genotypes 1 ...
Tenofovir disoproxil
Tenofovir disoproxil systemic is used for hepatitis b, HIV Infection, nonoccupational exposure ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.